Saliva Collection Devices Market To Witness Robust Expansion Throughout The Forecast Period 2018 - 2026

Saliva Collection Devices Market Demands and
Growth Prediction, Outlook 2018- 2026
Saliva Collection Devices Market, by Site of Collection (Whole Saliva, Glandular
Saliva, (Parotid Saliva, Submandibular/Sublingual Saliva, and Minor Glands)),
by Technique, (Resting, Mechanical, and Acid Stimulations), by Product Type
(Saliva Collection Kits, Saliva Collection Aids, Saliva Cryostorage Box, Oral
Swab, and Fluid Specific Devices), by Application (Pharma and Biotech
Industry, Forensics, Diagnostic and Pathology Laboratories, Dentistry, and
Research Institutes) - Size, Share, Outlook, and Opportunity Analysis, 20182026
The Global Saliva Collection Devices Market was valued at US$ 1,571.7 million in 2017, and is
expected to witness a CAGR of 10.8% over the forecast period (2018 – 2026).
Saliva is the most favored sample of choice in diagnosis due to ease of collection. Salivary
biomolecules have provided an aperture in surveying a person’s health and well-being. Saliva contains
a myriad of salivary proteins, which could serve as biological markers for diagnosing and tracking the
progression of various health conditions, as well as monitoring the effectiveness of medication. Saliva
collection devices allow a person to collect resting (unstimulated) saliva or stimulated saliva either via
mechanical stimulation or acid stimulation.
Market Dynamics
Rising research activities for saliva collection devices is expected to boost growth of the saliva
collection devices in the market. For instance, in July 2017, EquiSal Tapeworm saliva test was
launched in the U.S. for detecting tapeworms from saliva of horses. EquiSal saliva collection kits are
used for saliva collection, which comprises swabs to be kept in oral cavity of horses.
Furthermore, new marketing strategies by key players are expected to drive growth of the saliva
collection devices market over the forecast period. For instance, in October 2018, Mayo Clinic and
Helix’s lab launched a solution called, Mayo Clinic GeneGuide. It allows shipment of saliva collection
kits to the individual within two days and furthermore, DNA is sequenced for identifying diseases.
Ask For Sample Copy Of This Business Research Report :
https://www.coherentmarketinsights.com/insight/request-sample/2523
Increasing number of saliva collection device approvals is expected to drive growth of the saliva
collection devices market
Increase in the number of approvals for saliva collection devices due to its rising need for rapid
diagnosis of life threatening diseases is expected to drive growth of the saliva collection devices
market. For instance, in February 2015, 23andMe, Inc., received U.S. Food and Drug Administration
(USFDA) approval to market the first direct-to-consumer genetic Oragene Dx saliva collection test kits
under a regulatory classification for novel devices. The company works with DNA Genotek, a
subsidiary of OraSure Technologies, Inc, for Oragene Dx saliva collection kits. Saliva collected by
these kits is then used to screen for Bloom Syndrome, a genetic disease.
Furthermore, in January 2015, DNA Genotek Inc., received USFDA approval for Oragene Dx intended
for use in the non?invasive collection of saliva samples. DNA from the saliva sample is then isolated,
stabilized, and legally marketed for DNA carrier screening genotyping tests.
Moreover, technological advancements for saliva collection of infants are also expected to increase
growth of the saliva collection devices market. For instance, Oasis Diagnostics, developed Pedia SAL
collection kit for infants. It allows saliva collection process with simplest design intended to not only
collect saliva samples but also relax infants during procedure. Saliva can then be expressed from the
collector using a compression tube directly into any of a variety of common laboratory vials.
Saliva Collection Devices Market- Competitive Landscape
Key players operating in the saliva collection devices market include Quest Diagnostics, Neogen
Corporation, AboGen, Inc., OraSure Technologies, Inc., Oasis Diagnostics Corporation, Alere, Porex
Corporation., and Salimetrics, LLC.
Saliva Collection Devices Market- Regional Analysis
Regional segmentation of the global saliva collection devices market comprises North America, Latin
America, Europe, Asia Pacific, Middle East, and Africa.
North America held the major share in the global saliva collection devices market during the forecast
period, owing to increasing number of new and innovative product launches in the U.S. For instance, in
June 2016, DNA Genotek launched saliva sample collection device ORAcollectDx, an alternative to
buccal swabs. The device, ORAcollectDx, is part of saliva-based DNA collection and stabilization
devices.
Asia Pacific is expected to witness the fastest growth in the global saliva collection devices market the
forecast period, due to increasing awareness for safe and easy diagnosis of various diseases through
number of symposiums and conferences organized in the region. For instance, in October 2016, Saliva
Technology Application Research Symposium was held by Queensland University of Technology, in
Australia. The conference highlighted emerging research, translational and technological advances such
as saliva biomarker development, innovative saliva collection devices, improving saliva stability and
transportation, rapid disease identification, saliva rheology, and many more.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]

The Global Saliva Collection Devices Market was valued at US$ 1,571.7 million in 2017, and is expected to witness a CAGR of 10.8% over the forecast period (2018 – 2026). Saliva is the most favored sample of choice in diagnosis due to ease of collection. Salivary biomolecules have provided an aperture in surveying a person’s health and well-being.